v2.4.0.6
Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2012
Schedule of Share-Based Compensation Expense

Share-based compensation expense is included in the following line items in our statement of operations:

 

     2012      2011      2010  

Cost of revenue

     2         1         1   

Research and development

     5         2         —     

Selling, general and administrative

     45         28         11   
  

 

 

    

 

 

    

 

 

 
     52         31         12   
Pre-IPO Plans [Member]
 
Summary of Stock Options and Share Rights and Changes

The following table summarizes the information about NXP’s outstanding Pre-IPO stock options and changes during 2012 and 2011.

Stock options

 

     2012      2011  
     Stock options     Weighted average
exercise price in
EUR
     Stock options     Weighted average
exercise price in
EUR
 

Outstanding at January 1

     16,128,196        24.46         18,050,123        23.30   

Granted

     —          —           —          —     

Exercised

     (544,462     7.65         (1,051,993     6.61   

Forfeited

     (469,518     21.86         (869,934     22.08   
  

 

 

   

 

 

    

 

 

   

 

 

 

Outstanding at December 31

     15,114,216        25.14         16,128,196        24.46   

Exercisable at December 31

     2,372,254        11.96         2,875,053        12.46   
Outstanding Options Issued

The outstanding options issued under the Pre-IPO plans are categorized by exercise prices as follows:

Euro-denominated

 

exercise price    Shares      Intrinsic value
in millions
 

2.00 – 9.50

     1,260,268         29   

15.00

     4,957,155         32   

20.00

     1,479,889         —     

30.00

     3,083,343         —     

40.00

     3,612,921         —     

50.00

     720,640         —     
  

 

 

    

 

 

 
     15,114,216         61   
Weighted Average Grant-Date Fair Value of Options Granted

Upon completion of the secondary offering on February 7, 2013, in total up to 38% of the options under the Pre-IPO Plans became exercisable, subject to applicable laws and regulations. If the secondary offering had occurred before end of 2012, then the exercisable number of options would have been 5,173,338 with a weighted average exercise price of €14.65.

 

     Weighted average
fair value in EUR
 

Weighted average grant-date fair value in euros of options granted during:

  

2010

     1.20   

2009

     1.80   
Summary of Status of Pre-IPO Equity Rights and Changes

A summary of the status of NXP’s Pre-IPO equity rights and changes during 2012 and 2011 is presented below. All equity rights have an exercise price of nil.

 

Equity rights

 

     2012      2011  
     Shares     Weighted average grant
date fair value

in EUR
     Shares     Weighted average grant
date fair value

in EUR
 

Outstanding at January 1

     444,395        9.34         472,742        9.13   

Granted

     —          —           —          —     

Released

     (381,630     9.10         —          —     

Forfeited

     —          —           (28,347     5.80   
  

 

 

   

 

 

    

 

 

   

 

 

 

Outstanding at December 31

     62,765        10.80         444,395        9.34   

Exercisable at December 31

     —          —           —          —     
Post-IPO Plan [Member]
 
Summary of Stock Options and Share Rights and Changes

A summary of the status of NXP’s Post-IPO stock options and share rights and changes during 2012 and 2011 is presented below.

 

Stock options

 

     2012      2011  
     Stock options     Weighted average
exercise

price in USD
     Stock options     Weighted average
exercise

price in USD
 

Outstanding at January 1

     7,366,908        15.49         3,749,932        13.27   

Granted

     4,972,081        23.36         4,045,537        17.35   

Exercised

     (637,858     14.14         (71,542     13.27   

Forfeited

     (791,017     15.94         (357,019     13.65   
  

 

 

   

 

 

    

 

 

   

 

 

 

Outstanding at December 31

     10,910,114        19.12         7,366,908        15.49   

Exercisable at December 31

     1,819,243        15.05         853,732        13.27   
Outstanding Options Issued

The outstanding options issued under the Post-IPO Plans are categorized by exercise price as follows:

USD-denominated

 

Year granted    Exercise price      Shares      Intrinsic value
in millions
     Weighted average
remaining
contractual term
 

2012

     23.49         4,047,450         11         9.8   

2012

     22.62         197,550         1         9.6   

2012

     26.32         158.930         —           9.3   

2012

     21.63         493,865         2         9.1   

2011

     25.01         86,492         —           8.1   

2011

     31.81         61,040         —           8.3   

2011

     19.78         82,365         1         8.6   

2011

     16.84         3,298,913         31         8.8   

2010

     13.27         2,483,509         32         7.8   
Summary of Performance Share Units

Performance share units

 

     2012      2011  
     Shares     Weighted average
grant date fair value

in USD
     Shares     Weighted average
grant date fair value

in USD
 

Outstanding at January 1

     1,487,149        16.00         846,819        13.27   

Granted

     1,171,600        23.35         987,225        17.38   

Vested

     (30,311     22.66         (249,962     13.27   

Forfeited

     (219,964     15.28         (96,933     13.27   
  

 

 

   

 

 

    

 

 

   

 

 

 

Outstanding at December 31

     2,408,474        19.55         1,487,149        16.00   
Summary of Restricted Shares Units

Restricted share units

 

     2012      2011  
     Shares     Weighted average
grant date fair
value in USD
     Shares     Weighted average
grant date fair
value in USD
 

Outstanding at January 1

     2,360,806        16.08         1,283,295        13.27   

Granted

     2,021,918        23.31         1,571,236        17.52   

Vested

     (849,289     15.72         (400,835     13.27   

Forfeited

     (233,312     16.74         (92,890     13.81   
  

 

 

   

 

 

    

 

 

   

 

 

 

Outstanding at December 31

     3,300,123        20.56         2,360,806        16.08